Search

• Written by: A. Vacca ×
• Journal or magazine: Current Drug Targets ×
• Clear filters

1 result for “Union Carbide Corporation”

1. Medical study · Medical research · 2011

   Dasatinib: an anti-tumour agent via Src inhibition

   …BCR-ABL fusion protein and SFKs, which led to dasatinib approval by the Food and Drug Administration (FDA) and the European Union for the treatment of imatinib-resistant or -intolerant CML, and Philadelphia chromosome-positive acute…